|
Utilidad del péptido Pro-BNP en el diagnóstico pronóstico y tratamiento de la insuficiencia cardíaca [Pro-BNP Peptide in the diagnosis and prognosis of heart failure] |
Brito V, Ciapponi A, Pichon-Riviere A, Augustovski F, García Martí S, Alcaraz A, Bardach A, López A, Rey-Ares L |
|
|
Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Brito V, Ciapponi A, Pichon-Riviere A, Augustovski F, García Martí S, Alcaraz A, Bardach A, López A, Rey-Ares L. Utilidad del péptido Pro-BNP en el diagnóstico pronóstico y tratamiento de la insuficiencia cardíaca. [Pro-BNP Peptide in the diagnosis and prognosis of heart failure] Buenos Aires: Institute for Clinical Effectiveness and Health Policy (IECS). Informe de Respuesta Rapida No. 406. 2015 Authors' objectives To assess the available evidence on the efficacy, safety and coverage related aspects regarding brain natriuretic peptide use for patients with acute or chronic heart failure. Authors' conclusions There is high quality evidence showing that BNP and NT pro-BNP have an adequate diagnostic and prognostic performance for HF. Moderate to low quality evidence shows a potential reduction in morbidity and mortality related to treatment adjustment based on natriuretic peptides, but further assessment is still necessary.
The clinical practice guidelines recommend BNP or NT pro-BNP use to differentiate the cause of dyspnea and to estimate prognosis in chronic and acute HF.
Coverage policies consider its use to adequately characterize dyspnea, whereas only some also include its testing to estimate prognosis and adjust treatment for acute or chronic HF.
Final publication URL www.iecs.org.ar Indexing Status Subject indexing assigned by CRD MeSH Diagnosis; Heart Failure; Natriuretic Peptide, Brains; Natriuretic Peptides; Prognosis Language Published Spanish Country of organisation Argentina English summary An English language summary is available. Address for correspondence Institute for Clinical Effectiveness and Health Policy, Viamonte 2146 - 3 Piso, C1056ABH Ciudad de Buenos Aires, Argentina Tel: +54 11 49 66 00 82 Fax:+54 11 49 53 40 58 Email: info@iecs.org.ar AccessionNumber 32015000879 Date abstract record published 21/07/2015 |
|
|
|